Remove Conditions Remove Data Remove Events Remove Programs
article thumbnail

RYAH Group Ships Devices for Use in Pilot Program with Medicann in Jersey, Channel Islands

Cannabis Law Report

In addition to the pilot program, the parties are working toward an exclusive, definitive supply and distribution agreement, which, if entered into, is expected to position Medicann as the sole supplier and distributor of the RYAH Smart Dry Herb Inhalers in the region. to reach 3.2 billion euros ($3.75 billion) by 2025. About RYAH Group, Inc.

Programs 100
article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Adverse events were mostly mild and resolved spontaneously.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Marinus Pharmaceuticals Announces New Clinical and Research Data to be Presented at American Epilepsy Society Meeting

Cannabis Law Report

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

article thumbnail

Study: Potential Adverse Drug Events When Combining THC with Other Medication

The Joint Blog

But as an older user-base with more complicated medical conditions continue to grow, it is important to understand how THC could adversely impact other co-administered medications. Medical cannabis is typically prescribed for patients with severe conditions including inflammatory conditions (e.g.,

Events 48
article thumbnail

Wake Network Retains CRO Santé Cannabis to Conduct Clinical Trials in Psilocybin Therapies

Cannabis Law Report

This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol. This relationship enables us to initiate our clinical research program and marks an important step for Wake in Canada.

article thumbnail

Tetra Bio-Pharma Files PCT Patent Application for Cannabis Plant Residue

Cannabis Law Report

Tetra Bio-Pharma ( TSX: TBP ) ( OTCQB: TBPMF ) ( FRA:JAM1 ) is a leader in cannabinoid-derived drug discovery and development with a FDA and a Health Canada cleared clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. For more information visit: www.tetrabiopharma.com.

article thumbnail

Tremor Video and Fyllo Partnership Allows Advertisers to Connect with Cannabis and CBD Consumers Across All Video Screens

Cannabis Law Report

“Partnering with Fyllo reinforces our commitment to delivering innovative data solutions designed to enhance our clients’ audience reach strategies,” said Jay Baum , Chief Commercial Officer at Tremor Video. Learn more about Tremor Video’s data-driven audience solutions at www.tremorvideo.com. Traditional segments (e.g.

CBD 52